Drug intelligence / Profile preview

5-iodo-2'-deoxyuridine-5'-monophosphate

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

5-Iodo‑2'‑deoxyuridine‑5'‑monophosphate (IdUMP) is a halogenated nucleoside monophosphate analog of deoxyuridine. It is the phosphorylated form of idoxuridine (IDU), an antiviral pyrimidine analog. As a nucleotide analog structurally similar to thymidine monophosphate (dTMP), it can be incorporated into DNA in place of thymidine during DNA synthesis. This incorporation disrupts normal DNA replication and function due to the presence of the iodine atom at position 5 on the uracil ring. **Mechanism of Action:** IdUMP acts primarily by mimicking natural nucleotides and being incorporated into viral or cellular DNA during replication. The presence of iodine at position 5 interferes with base pairing and inhibits enzymes involved in nucleotide metabolism and DNA polymerization—ultimately inhibiting viral replication or cell proliferation[1][4][6]. While idoxuridine itself is used clinically as an antiviral agent for herpes simplex keratitis[4], its monophosphate form (IdUMP) is mainly used experimentally in molecular biology research. **Primary Indications/Use:** There are no approved clinical indications for IdUMP; it is considered experimental and primarily utilized as a biochemical tool in studies involving DNA synthesis inhibition and antiviral mechanisms[1][6].

Other names
(((2R,3S,5R)-3-hydroxy-5-(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl)methoxy)phosphonic acid{[(2R,3S,5R)-3-hydroxy-5-(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1yl)oxolan–2–yl]methoxy}phosphonic acid1763–02–65′–Uridylic acid, 2′–deoxy–5–iodo–
02

Targets

DNA polymerase familyTS (Thymidylate synthase)

Beyond the preview

Go deeper on 5-iodo-2'-deoxyuridine-5'-monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-iodo-2'-deoxyuridine-5'-monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call